SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 186.52 |
| Enterprise Value ($M) | 26.81 |
| Book Value ($M) | 170.18 |
| Book Value / Share | 2.07 |
| Price / Book | 1.10 |
| NCAV ($M) | 125.15 |
| NCAV / Share | 1.52 |
| Price / NCAV | 1.49 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.41 |
| Current Ratio | 8.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 162.27 |
| Assets | 207.29 |
| Liabilities | 37.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -132.58 |
| Net Income | -142.66 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -93.72 |
| Cash from Investing | -4.46 |
| Cash from Financing | 0.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Orbimed Advisors Llc | 11.90 | 0.00 | |
| 13G | Millennium Management Llc | 5.20 | ||
| 13G/A | Tang Capital Partners Lp | 7.80 | 159.74 | |
| 13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Rtw Investments, Lp | 9.60 | -2.52 | |
| 13G | Morgan Stanley | 6.40 | 86.10 | |
| 13G/A | BlackRock Inc. | 3.00 | -3.24 | |
| 13D/A | Carlyle Group Inc. | 4.10 | 42.14 | |
| 13G | Ra Capital Management, L.p. | 9.99 | ||
| 13G/A | Cowen Financial Products LLC | 6.29 | -13.63 | |
| 13G/A | State Street Corp | 1.48 | -71.96 | |
| 13G | Commodore Capital Lp | 9.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 118,534 | 864,481 | 13.71 | |
| 113,203 | 681,534 | 16.61 | |
| 21,548 | 171,891 | 12.54 | |
| 111,588 | 144,219 | 77.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACAB – Atlantic Coastal Acquisition Corp. II | ACIU – AC Immune SA |
| ACRV – Acrivon Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io